Lexicon Pharmaceuticals (LXRX)
Lexicon Pharmaceuticals Income Statement
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Income | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Revenue | 0.30M | 0.343M | 0.355M | 0.555M | 0.596M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cost of Revenue | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Gross Profit | 0.30M | 0.343M | 0.355M | 0.555M | 0.596M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Research & Development Expense | 23.04M | 28.11M | 19.66M | 20.14M | 23.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Selling, General, & Admin. Expense | 4.565M | 4.01M | 4.055M | 4.532M | 4.753M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation & Amortization | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Operating Interest Expense | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Operating Income (Expense) | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Operating Expenses | 29.68M | 33.68M | 26.05M | 26.48M | 29.73M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Operating Income | -29.38M | -33.34M | -25.69M | -25.93M | -29.14M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Non-Operating Income | -0.485M | -0.503M | -0.412M | -0.712M | -0.493M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Pretax Income | -29.87M | -33.84M | -26.10M | -26.64M | -29.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Provision for Income Taxes | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Income after Tax | -29.87M | -33.84M | -26.10M | -26.64M | -29.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity In Affiliates | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income Before Extraordinaries & Disc. Operations | -29.87M | -33.84M | -26.10M | -26.64M | -29.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investment Gains/Losses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Income/Charges | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Income from Discontinued Operations | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Income | -29.87M | -33.84M | -26.10M | -26.64M | -29.63M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Earnings Per Share Data | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Average Shares to compute diluted EPS | 480.32 | 340.76 | 337.68 | 337.67 | 337.53 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Average Shares used to compute basic EPS | 480.32 | 340.76 | 337.68 | 337.67 | 337.53 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Basic net | -0.06 | -0.09 | -0.08 | -0.08 | -0.09 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| EPS - Diluted net | -0.06 | -0.09 | -0.08 | -0.08 | -0.09 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
